Dr. Vince Clinical Research Announces Addition of Principal Investigator Steven Hull, M.D.

OVERLAND PARK, KS, December 7, 2021 – Dr. Vince Clinical Research (DVCR) added depth to its medical team with the addition of industry veteran Steven Hull, M.D., FCCP, FAASM, as a Principal Investigator for the new clinical research organization.

Dr. Hull joins DVCR as a seasoned researcher, having participated in more than 350 clinical trials as an Investigator or medical monitor. He has been board certified in internal medicine, pulmonary disease and sleep medicine and holds certificates in numerous clinical research competencies. 

“As we assemble a world-class clinical research team in Kansas City, Dr. Hull will be a key asset to our sponsors, study volunteers and staff. His comprehensive background in clinical research is instrumental to our innovative approach for early development trials,” said CEO and Medical Director Brad Vince, D.O.

Hull’s clinical research experience is exceptionally diverse. Prior to joining DVCR, Hull served as an independent medical monitor for multiple trials, including a study funded by the National Institutes of Health. He has also served as the Chief Medical Officer of Graymark Healthcare, a Clinical Assistant Professor with the department of Family Medicine at Kansas City University, and an Associate Editor for the Journal Sleep and the Journal of Clinical Sleep Medicine.

“It is an honor to join the Dr. Vince team as a Principal Investigator. The expertise and dedication of the leadership team at DVCR was a critical factor in my decision to join the organization. Their commitment to data quality and sponsor satisfaction separates them from other CROs,” said Hull.

About Dr. Vince Clinical Research
Dr. Vince Clinical Research (DVCR) is a full-service contract research organization (CRO) specializing in early phase trials in both healthy normal volunteers and patient populations across a wide range of trial designs and multiple therapeutic areas such as neuroscience, psychiatry, substance abuse, pain, cardiometabolic disorders, infectious diseases and others. CRO services include project management, data management, biostatistics, monitoring, PK/PD analysis, medical writing as well as site feasibility and management for multi-center trials. Additionally, DVCR operates one of the most innovative and technologically advanced clinical pharmacology units in the world with over 90 beds for overnight confinement, a cGMP compliant pharmacy as well as luxurious amenities to support diverse study participant recruitment and retention. By leveraging technology and one of the country’s most experienced leadership teams in early clinical development, DVCR provides Smarter Faster Data® to their biopharmaceutical clients.

Website: sponsors.drvince.com
LinkedIn: https://www.linkedin.com/company/76214880 

For more information, contact:
Zach Bader
Vice President, Business Development
Dr. Vince Clinical Research